Cardiomyopathy

March 14, 2021

LncRNA-based regenerative cardiovascular therapy: LncRNA LET inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 14/February/2021, 11.43 pm

LncRNA-based regenerative cardiovascular therapy: LncRNA LET inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 14/February/2021, 11.43 pm https://genomediscovery.org/wp-content/uploads/2021/03/LncRNA-LET-based-therapy-improves-functional-recovery-after-Myocardial-infarction.jpg-3.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2021/03/LncRNA-LET-based-therapy-improves-functional-recovery-after-Myocardial-infarction.jpg-3.jpg March 14, 2021 March 14, 2021

What they say: A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March 2013 issue of the journal Nature, by Profs. Stefanie Dimmeler…

February 12, 2021

LncRNA-based regenerative cardiovascular therapy: LncRNA PEAMIR inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 13/February/2021, 12.02 am

LncRNA-based regenerative cardiovascular therapy: LncRNA PEAMIR inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 13/February/2021, 12.02 am https://genomediscovery.org/wp-content/uploads/2021/02/LncRNA-PEAMIR-prevents-cardiomyocyte-dysfunction-and-cardiac-ageing-through-up-regulation-of-PNUTS2.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2021/02/LncRNA-PEAMIR-prevents-cardiomyocyte-dysfunction-and-cardiac-ageing-through-up-regulation-of-PNUTS2.jpg February 12, 2021 February 12, 2021

February 12, 2021

Molecular regenerative cardiovascular therapy: GAB2 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 12/February/2021, 5.45 am

Molecular regenerative cardiovascular therapy: GAB2 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 12/February/2021, 5.45 am https://genomediscovery.org/wp-content/uploads/2021/02/Gab2-prevents-cardiomyocyte-dysfunction-and-cardiac-ageing-through-up-regulation-of-PNUTS.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2021/02/Gab2-prevents-cardiomyocyte-dysfunction-and-cardiac-ageing-through-up-regulation-of-PNUTS.jpg February 12, 2021 February 12, 2021

February 10, 2021

LncRNA-based regenerative cardiovascular therapy: LncRNA ADPGK-AS1 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 10/February/2021

LncRNA-based regenerative cardiovascular therapy: LncRNA ADPGK-AS1 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 10/February/2021 https://genomediscovery.org/wp-content/uploads/2021/02/LncRNA-ADPGK-AS1-prevents-cardiomyocyte-dysfunction-and-cardiac-ageing.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2021/02/LncRNA-ADPGK-AS1-prevents-cardiomyocyte-dysfunction-and-cardiac-ageing.jpg February 10, 2021 February 12, 2021

February 10, 2021

LncRNA-based regenerative cardiovascular therapy: LncRNACASC8 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 10/February/2021, 10.39 pm

LncRNA-based regenerative cardiovascular therapy: LncRNACASC8 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 10/February/2021, 10.39 pm https://genomediscovery.org/wp-content/uploads/2021/02/LncRNA-CASC8-Promotes-cardiac-repair-and-functional-recovery-after-myocardial-infarction-2-1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2021/02/LncRNA-CASC8-Promotes-cardiac-repair-and-functional-recovery-after-myocardial-infarction-2-1.jpg February 10, 2021 February 10, 2021

February 10, 2021

Molecular regenerative cardiovascular therapy: MUC1-C inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 10/February/2021, 10.27 pm

Molecular regenerative cardiovascular therapy: MUC1-C inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 10/February/2021, 10.27 pm https://genomediscovery.org/wp-content/uploads/2021/02/MUC1C-Promotes-cardiac-repair-and-functional-recovery-after-myocardial-infarction-3-1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2021/02/MUC1C-Promotes-cardiac-repair-and-functional-recovery-after-myocardial-infarction-3-1.jpg February 10, 2021 February 10, 2021

Popular Post